Related Experiment Video

Updated: Jul 1, 2026

Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease
06:25

Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease

Published on: March 29, 2024

Insulin-like growth factor-binding protein-5 (IGFBP-5) acts as a tumor suppressor by inhibiting angiogenesis

Seung Bae Rho1, Seung Myung Dong, Sokbom Kang

  • 1Research Institute, National Cancer Center, 809 Madu 1-dong, Ilsan-gu, Republic of Korea. sbrho@ncc.re.kr

Carcinogenesis
|September 9, 2008
PubMed

Insights

Insulin-like growth factor-binding protein-5 (IGFBP-5) acts as an antiangiostatic factor, suppressing tumor growth and vascularity. This discovery highlights IGFBP-5

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Insulin-like growth factor-binding protein-5 (IGFBP-5) is a key regulator of cell growth and apoptosis within the IGFBP family.
  • IGFBP-5's role in modulating IGF-stimulated signaling pathways is well-established.
  • Its potential as an antiangiostatic factor requires further characterization.

Purpose of the Study:

  • To investigate the specific function of IGFBP-5 as a novel antiangiostatic factor.
  • To elucidate the molecular mechanisms underlying IGFBP-5's effect on angiogenesis.
  • To evaluate the therapeutic potential of IGFBP-5 in cancer models.

Main Methods:

  • Overexpression of IGFBP-5 in relevant cellular and in vivo models.
  • Assessment of endothelial cell tube formation and biological functions.
  • Analysis of key signaling pathway components, including phosphorylated protein kinase B and phosphorylated endothelial NO synthase.
  • Evaluation of tumor growth and vascularity in a human ovarian cancer xenograft model.

Main Results:

  • Overexpression of IGFBP-5 significantly suppressed endothelial cell tube formation and angiostatic activity.
  • IGFBP-5 overexpression led to reduced levels of phosphorylated protein kinase B and phosphorylated endothelial NO synthase.
  • IGFBP-5 expression inhibited tumor growth and reduced tumor vascularity in a human ovarian cancer xenograft model.

Conclusions:

  • IGFBP-5 functions as a novel antiangiostatic factor.
  • IGFBP-5 inhibits angiogenesis by downregulating key signaling pathways involved in its regulation.
  • IGFBP-5 demonstrates potential as a tumor suppressor by targeting angiogenesis.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...